Dexmedetomidine during kidney transplant to protect heart safety
Treatments studied
Part of Kidney & urinary clinical trials.
This trial looks at using dexmedetomidine around the time of a kidney transplant to see if it is safe and well-tolerated, especially for heart rhythm and blood flow. If you’re scheduled for an urgent or elective kidney transplant, this may be considered as part of your anesthesia plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having an urgent or elective kidney transplant for advanced kidney failure
- You are age 18 or older
- You do not have a known allergy to dexmedetomidine (or clonidine)
- Your usual heart rate before surgery is not too low (not under 50 beats per minute)
- You do not have certain serious heartbeat rhythm problems unless you have a pacemaker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called dexmedetomidine, given during general anesthesia, helps keep your heart rate and blood pressure stable during outpatient surgery. It may be an option if you are having a minor surgery and are not on certain heart medications.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This trial tests adding a sedative medicine called dexmedetomidine to standard anesthesia for children aged 3 to 12 who are having a procedure to close a hole in their heart (atrial septal defect). The goal is to see if it helps them recover more smoothly.
This trial studies whether adding a medication called dexmedetomidine during cancer surgery can improve long-term survival. It is for older adults having major cancer surgery that lasts at least two hours and who will need a pain pump after the operation.
This study tests whether a sedative called remimazolam works well and safely for people getting a kidney transplant. It might help you stay calm and comfortable during surgery.
This trial tests if dexmedetomidine, a sedative, can help protect the kidneys of critically ill patients with sepsis who develop acute kidney injury (a sudden drop in kidney function). It is for adults in the ICU who need a breathing tube or mask within 48 hours of kidney injury.
Hear when a new Renal Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.